دورية أكاديمية
Antibody-drug conjugate targeting folate receptor α: a new milestone in personalized medicine for high-grade serous ovarian cancer.
| العنوان: | Antibody-drug conjugate targeting folate receptor α: a new milestone in personalized medicine for high-grade serous ovarian cancer. |
|---|---|
| المؤلفون: | Gonzalez-Martin A; Medical Oncology Department, Cancer Center Clinica Universidad de Navarra, Madrid, Spain agonzalezma@unav.es. |
| المصدر: | International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [Int J Gynecol Cancer] 2024 Aug 05; Vol. 34 (8), pp. 1126-1127. Date of Electronic Publication: 2024 Aug 05. |
| نوع المنشور: | Journal Article; Editorial |
| اللغة: | English |
| بيانات الدورية: | Publisher: BMJ Country of Publication: England NLM ID: 9111626 Publication Model: Electronic Cited Medium: Internet ISSN: 1525-1438 (Electronic) Linking ISSN: 1048891X NLM ISO Abbreviation: Int J Gynecol Cancer Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2019- : [London] : BMJ Original Publication: Cambridge, MA, USA : Blackwell Scientific Publications, c1991- |
| مواضيع طبية MeSH: | Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/pathology , Precision Medicine*/methods , Immunoconjugates*/therapeutic use , Immunoconjugates*/administration & dosage , Folate Receptor 1*/antagonists & inhibitors, Humans ; Female ; Cystadenocarcinoma, Serous/drug therapy ; Cystadenocarcinoma, Serous/pathology |
| مستخلص: | Competing Interests: Competing interests: None declared. |
| فهرسة مساهمة: | Keywords: Ovary |
| المشرفين على المادة: | 0 (Immunoconjugates) 0 (Folate Receptor 1) |
| تواريخ الأحداث: | Date Created: 20240711 Date Completed: 20240805 Latest Revision: 20240805 |
| رمز التحديث: | 20240806 |
| DOI: | 10.1136/ijgc-2024-005861 |
| PMID: | 38991657 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!